Risk Factors for Worsening of Bone Loss in Patients Newly Diagnosed with Inflammatory Bowel Disease.

Yi Yin Xiaofeng Lu Zhun Li Song Liu Lihua Shao Lei Cao Rui-Qing Liu Liang-Yu Huang Zhen-Xing Zhu Zhen Guo Yi Li Wei-Ming Zhu

Published in: Gastroenterology research and practice (2022)

Metabolic bone disease is common in IBD patients, and there is a significant increase in prevalence of bone loss over time. Postmenopausal female, malnourished patients, and those requiring corticosteroid treatment are at risk for persistent bone loss. Therefore, BMD measurements and early intervention with supplementation of calcium and vitamin D are recommended in IBD patients with high-risk factors.

Keyphrases

newly diagnosed
bone loss
end stage renal disease
risk factors
ejection fraction
chronic kidney disease
randomized controlled trial
patient reported outcomes
bone mineral density
postmenopausal women
combination therapy
soft tissue